Data from several clinical trials of ADCETRIS to be presented at ASCO annual meeting

[News]

Seattle Genetics, Inc. today announced that data from several clinical trials of ADCETRIS (brentuximab vedotin) will be presented at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting being held June 1-5, 2012 in Chicago, IL.

More... (http://www.news-medical.net/news/20120604/Data-from-several-clinical-trials-of-ADCETRIS-to-be-presented-at-ASCO-annual-meeting.aspx)